Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients

Clinical trial NCT05369312 · UNKNOWN

Trial details

NCT number: NCT05369312
Sponsor: Betta Pharmaceuticals Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Non-small Cell Lung Cancer Pancreatic Cancer Colorectal Cancer

Start date: 2022-06-01
Primary completion: 2024-05-01
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.